Add to Favorites Newsroom RSS Share
fb-shareJoslin Diabetes Center
Boston, MA USA

Our News on Newswise

Pushing early beta-cell proliferation can halt autoimmune attack in type 1 diabetes model

Researchers at Joslin have found that increasing the proliferation and turnover of beta cells before signs of type 1 diabetes could halt the development of the disease.
6-May-2019 11:05 AM EDT Add to Favorites


Study sheds light on strategies for managing diabetic macular edema in people with good vision

BOSTON – (April 29, 2019) – Newly available results will influence the standard approach for treating diabetic macular edema in patients with good vision, thanks to a study published today in the Journal of the American Medical Association. The...
1-May-2019 3:05 PM EDT Add to Favorites

Researchers identify new novel circulating proteins that are involved in progression of diabetic kidney disease to end stage renal failure

BOSTON – (April 22, 2019) -- In a breakthrough study published today in Nature Medicine, researchers at Joslin Diabetes Center have identified a group of 17 circulating inflammatory proteins that are consistently associated with the development...
22-Apr-2019 3:05 PM EDT Add to Favorites

Breast Milk Analyses Could Lead to New Opportunities for Reducing Earliest Risk of Childhood Obesity

BOSTON – (April 10, 2019) -- New research suggests the composition of breast milk in normal weight mothers differs from that of overweight mothers, and that variations in small molecule metabolites found in breast milk are possible risk factors...
10-Apr-2019 12:05 PM EDT Add to Favorites


New Evidence Links Lifespan Extension to Metabolic Regulation of Immune System

Researchers at Joslin Diabetes Center have uncovered a new mechanism of lifespan extension that links caloric restriction with immune system regulation.
18-Mar-2019 12:05 PM EDT Add to Favorites


Insulin Signaling Failures in the Brain Linked to Alzheimer’s Disease

Scientists continue to find evidence linking Type 2 diabetes with Alzheimer’s disease, the most common form of dementia and the seventh leading cause of death in the United States. However, little is understood about the mechanism by which the two...
13-Mar-2019 12:20 PM EDT Add to Favorites


SGLT-2 inhibitors induce a fasting state that triggers metabolic benefits

Joslin researchers detail how SGLT-2 inhibitors induce a fasting state in the body without requiring the patient to sharply cut back on food intake. This triggers a host of beneficial metabolic effects.
6-Mar-2019 12:05 PM EST Add to Favorites


Protein Released From Fat Following Exercise Improves Glucose Tolerance, and Health

BOSTON – (February 11, 2019) – It’s well-known that exercise improves health, but understanding how it makes you healthier on a molecular level is the question researchers at Joslin Diabetes Center are answering. After performing experiments...
11-Feb-2019 4:50 PM EST Add to Favorites

see all news

Our Experts on Newswise

Diabetes & Breast Cancer - Elizabeth Halprin MD Talks About the Important Struggle to Balance Both Diseases

12-Oct-2017 10:05 AM EDT


Dr. Lori Laffel, Chief of Pediatrics at Joslin Diabetes Center, Available to Comment on Type 1 Diabetes and Life Expectancy Studies

6-Jan-2015 11:00 AM EST


Back to School with Dr. Lori Laffel from Joslin Diabetes Center

Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25...
15-Aug-2014 8:00 AM EDT

Expert Available: Bariatric Surgery for Diabetes

The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT

see all experts

Our YouTube Videos


Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. Joslin is dedicated to finding a cure for diabetes and ensuring that people with diabetes live long, healthy lives. We develop and disseminate innovative patient therapies and scientific discoveries throughout the world. Joslin is an independent, non-profit institution affiliated with Harvard Medical School, and one of only 11 NIH-designated Diabetes Research Centers in the U.S.

For more information, visit or follow @joslindiabetes


Jeffrey Bright
Director, Communications


Twitter twitter-icon

Chat now!